{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T01:54:19Z","timestamp":1789178059475,"version":"build-2803163510"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T00:00:00Z","timestamp":1777075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003500","name":"Universit\u00e0 degli Studi di Padova","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003500","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiol med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Pompe disease (PD) is a rare genetic disorder, caused by the lysosomal acid alpha-glucosidase enzyme deficiency leading to accumulation of glycogen, primarily in skeletal and respiratory muscles, but also in the heart. In both known PD forms, namely infantile (IOPD) and late-onset (LOPD), the prevalence and nature of myocardial involvement are still to be clarified. Cardiovascular magnetic resonance (CMR) may help to detect unrecognized alterations contributing to patients\u2019 management. This study aimed to systematically review PD CMR features. We conducted a systematic search of three electronic databases (PubMed, Scopus, and Web of Science) up to February 2024, without language or time interval restriction. Two reviewers performed the search and selection process, data extraction, and synthesis. We resolved disagreements by consensus and\/or involving a third reviewer. The included studies have been classified according to the Oxford Centre for Evidence Based Medicine (CEBM) grading system. Out of 276 articles, 11 papers were finally included: seven about IOPD and four regarding LOPD. According to CEBM, seven were level 5, one was level 4, two were level 3, and one was level 2. Six studies reported qualitative late-gadolinium enhancement tissue characterization, 1 described cardiac infiltration on TIRM sequences, 3 explored changes in ExtraCellular Volume and, among these, 2 evaluated also T1\/T2 mapping and perfusion; one study assessed the management after therapy through T1 mapping. Literature data regarding CMR features in PD are limited and based on nonparametric assessment mainly. Further investigations, involving also mapping techniques, are required to better understand PD cardiac involvement.<\/jats:p>","DOI":"10.1007\/s11547-026-02199-9","type":"journal-article","created":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T05:53:21Z","timestamp":1777096401000},"page":"1205-1216","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiac magnetic resonance in Pompe disease: a systematic literature review"],"prefix":"10.1007","volume":"131","author":[{"given":"Amalia","family":"Lupi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Schiavone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenza","family":"Gragnaniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cervaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Crim\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Quaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,25]]},"reference":[{"key":"2199_CR1","doi-asserted-by":"publisher","unstructured":"Parenti G, Fecarotta S, Alagia M, Attaianese F, Verde A, Tarallo A, Gragnaniello V, Ziagaki A, Guimaraes MJ, Aguiar P, Hahn A, Azevedo O, Donati MA, Kiec-Wilk B, Scarpa M, van der Beek NAME, Del Toro Riera M, Germain DP, Huidekoper H, van den Hout JMP, van der Ploeg AT; the MetabERN Subnetwork for Lysosomal Disorders (2024) The European reference network for metabolic diseases (MetabERN) clinical pathway recommendations for Pompe disease (acid maltase deficiency, glycogen storage disease type II). Orphanet J Rare Dis 19(1):408. https:\/\/doi.org\/10.1186\/s13023-024-03373-w","DOI":"10.1186\/s13023-024-03373-w"},{"issue":"5 Suppl","key":"2199_CR2","doi-asserted-by":"publisher","first-page":"S35","DOI":"10.1016\/j.jpeds.2004.01.053","volume":"144","author":"PS Kishnani","year":"2004","unstructured":"Kishnani PS, Howell RR (2004) Pompe disease in infants and children. J Pediatr 144(5 Suppl):S35-43. https:\/\/doi.org\/10.1016\/j.jpeds.2004.01.053","journal-title":"J Pediatr"},{"issue":"2","key":"2199_CR3","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1542\/peds.112.2.332","volume":"112","author":"HM van den Hout","year":"2003","unstructured":"van den Hout HM, Hop W, van Diggelen OP, Smeitink JA, Smit GP, Poll-The BT, Bakker HD, Loonen MC, de Klerk JB, Reuser AJ, van der Ploeg AT (2003) The natural course of infantile Pompe\u2019s disease: 20 original cases compared with 133 cases from the literature. Pediatrics 112(2):332\u2013340. https:\/\/doi.org\/10.1542\/peds.112.2.332","journal-title":"Pediatrics"},{"issue":"1-2","key":"2199_CR4","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.jns.2008.07.013","volume":"275","author":"NA van der Beek","year":"2008","unstructured":"van der Beek NA, Soliman OI, van Capelle CI, Geleijnse ML, Vletter WB, Kroos MA, Reuser AJ, Frohn-Mulder IM, van Doorn PA, van der Ploeg AT (2008) Cardiac evaluation in children and adults with Pompe disease sharing the common c.\u221232-13T&gt;G genotype rarely reveals abnormalities. J Neurol Sci 275(1\u20132):46\u201350. https:\/\/doi.org\/10.1016\/j.jns.2008.07.013","journal-title":"J Neurol Sci"},{"issue":"7","key":"2199_CR5","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1097\/GIM.0b013e3182142966","volume":"13","author":"D Forsha","year":"2011","unstructured":"Forsha D, Li JS, Smith PB, van der Ploeg AT, Kishnani P, Pasquali SK (2011) Late-onset treatment study investigators. Cardiovascular abnormalities in late-onset Pompe disease and response to enzyme replacement therapy. Genet Med 13(7):625\u2013631. https:\/\/doi.org\/10.1097\/GIM.0b013e3182142966","journal-title":"Genet Med"},{"issue":"5","key":"2199_CR6","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1007\/s10554-015-0629-7","volume":"31","author":"DA Morris","year":"2015","unstructured":"Morris DA, Blaschke D, Krebs A, Canaan-Kuhl S, Plockinger U, Knobloch G, Walter TC, Kuhnle Y, Boldt L-H, Kraigher-Krainer E, Pieske B, Haverkamp W (2015) Structural and functional cardiac analyses using modern and sensitive myocardial techniques in adult pompe disease. Int J Cardiovasc Imaging 31(5):947\u2013956","journal-title":"Int J Cardiovasc Imaging"},{"issue":"4","key":"2199_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1111\/j.1365-2796.2008.01966.x","volume":"264","author":"OI Soliman","year":"2008","unstructured":"Soliman OI, van der Beek NA, van Doorn PA, Vletter WB, Nemes A, Van Dalen BM, ten Cate FJ, van der Ploeg AT, Geleijnse ML (2008) Cardiac involvement in adults with Pompe disease. J Intern Med 264(4):333\u2013339. https:\/\/doi.org\/10.1111\/j.1365-2796.2008.01966.x","journal-title":"J Intern Med"},{"issue":"14","key":"2199_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13142439","volume":"13","author":"A Pepe","year":"2023","unstructured":"Pepe A, Crim\u00ec F, Vernuccio F, Cabrelle G, Lupi A, Zanon C, Gambato S, Perazzolo A, Quaia E (2023) Medical radiology: current progress. Diagnostics (Basel) 13(14):2439. https:\/\/doi.org\/10.3390\/diagnostics13142439","journal-title":"Diagnostics (Basel)"},{"issue":"37","key":"2199_CR9","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, Arbustini E, Barriales-Villa R, Basso C, Bezzina CR, Biagini E, Blom NA, de Boer RA, De Winter T, Elliott PM, Flather M, Garcia-Pavia P, Haugaa KH, Ingles J, Jurcut RO, Klaassen S, Limongelli G, Loeys B, Mogensen J, Olivotto I, Pantazis A, Sharma S, Van Tintelen JP, Ware JS, Kaski JP, ESC Scientific Document Group (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 44(37):3503\u20133626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194","journal-title":"Eur Heart J"},{"key":"2199_CR10","unstructured":"http:\/\/www.cebm.net\/index.aspx?o=5653"},{"issue":"10","key":"2199_CR11","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, Stephenson M, Aromataris E (2020) Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth 18(10):2127\u20132133","journal-title":"JBI Evid Synth"},{"key":"2199_CR12","unstructured":"Wells GA, Shea B, O'Connell D et al (2011) The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses"},{"key":"2199_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinnes LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, Moher D (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71. https:\/\/doi.org\/10.1136\/bmj.n71","journal-title":"BMJ"},{"key":"2199_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n160","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, Chou R, Glanville J, Grimshaw JM, Hrobjartsson A, Lalu MM, Li T, Loder EW, Mayo-Wilson E, McDonald S, McGuinnes LA, Stewart LA, Thomas J, Tricco AC, Welch VA, Whiting P, McKenzie JE (2021) PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ 372:n160. https:\/\/doi.org\/10.1136\/bmj.n160","journal-title":"BMJ"},{"issue":"4","key":"2199_CR15","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.ymgme.2010.07.011","volume":"101","author":"PC Barker","year":"2010","unstructured":"Barker PC, Pasquali SK, Darty S, Ing RJ, Li JS, Kim RJ, DeArmey S, Kishnani PS, Campbell MJ (2010) Use of cardiac magnetic resonance imaging to evaluate cardiac structure, function and fibrosis in children with infantile Pompe disease on enzyme replacement therapy. Mol Genet Metab 101(4):332\u2013337. https:\/\/doi.org\/10.1016\/j.ymgme.2010.07.011","journal-title":"Mol Genet Metab"},{"issue":"1","key":"2199_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-016-0311-9","volume":"18","author":"M Boentert","year":"2016","unstructured":"Boentert M, Florian A, Dr\u00e4ger B, Young P, Yilmaz A (2016) Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach. J Cardiovasc Magn Reson 18(1):91. https:\/\/doi.org\/10.1186\/s12968-016-0311-9","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"2199_CR17","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/00004728-198609000-00030","volume":"10","author":"RA Boxer","year":"1986","unstructured":"Boxer RA, Fishman M, LaCorte MA, Singh S, Cooper RS (1986) Cardiac MR imaging in Pompe disease. J Comput Assist Tomogr 10(5):857\u2013859. https:\/\/doi.org\/10.1097\/00004728-198609000-00030","journal-title":"J Comput Assist Tomogr"},{"issue":"6","key":"2199_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12062365","volume":"12","author":"V Gragnaniello","year":"2023","unstructured":"Gragnaniello V, Rizzardi C, Commone A, Gueraldi D, Maines E, Salviati L, Di Salvo G, Burlina AB (2023) Unusual evolution of hypertrophic cardiomyopathy in non-compaction myocardium in a Pompe disease patient. J Clin Med 12(6):2365. https:\/\/doi.org\/10.3390\/jcm12062365","journal-title":"J Clin Med"},{"key":"2199_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s13052-025-01837-8","author":"MA Hussein","year":"2025","unstructured":"Hussein MA, ElTaher H, Mahmoud R, Sobh D, Al-Haggar M (2025) Clinical manifestations in Egyptian Pompe disease patients: molecular variability and enzyme replacement therapy (ERT) outcomes. Ital J Pediatr. https:\/\/doi.org\/10.1186\/s13052-025-01837-8","journal-title":"Ital J Pediatr"},{"issue":"9","key":"2199_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.92598","volume":"17","author":"G Lasam","year":"2025","unstructured":"Lasam G, Lasam MKC (2025) In thickness and in health: delayed-onset Pompe disease resembling hypertrophic cardiomyopathy. Cureus 17(9):e92598. https:\/\/doi.org\/10.7759\/cureus.92598","journal-title":"Cureus"},{"issue":"16","key":"2199_CR21","first-page":"3665","volume":"21","author":"M Walczak-Galezewska","year":"2017","unstructured":"Walczak-Galezewska M, Skrypnik D, Szulinska M, Musialik K, Skrypnik K, Bogdanski P (2017) Late-onset Pompe disease in a 54 year-old sportsman with an episode of syncope: a case report. Eur Rev Med Pharmacol Sci 21(16):3665\u20133667","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"16","key":"2199_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2024.102446","volume":"29","author":"W Wang","year":"2024","unstructured":"Wang W, Zhang X, Lyu J, Yan F, Lou X (2024) Assessing gene therapy efficacy in infantile-onset Pompe disease: myocardial native T1 values of CMR. JACC Case Rep 29(16):102446. https:\/\/doi.org\/10.1016\/j.jaccas.2024.102446","journal-title":"JACC Case Rep"},{"issue":"7","key":"2199_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18330","volume":"9","author":"Y Zhong","year":"2023","unstructured":"Zhong Y, Zhang W, Fan W (2023) Hypertrophy cardiomyopathy: a case of infantile-onset Pompe disease in cardiac magnetic resonance findings. Heliyon 9(7):e18330. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e18330","journal-title":"Heliyon"},{"key":"2199_CR24","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jeaf006","author":"Y Zhu","year":"2025","unstructured":"Zhu Y, Liu X, Hu L, Guo Y, Wen L (2025) Cardiovascular magnetic resonance abnormalities in an infantile-onset Pompe disease. Eur Heart J Cardiovasc Imaging. https:\/\/doi.org\/10.1093\/ehjci\/jeaf006","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"2","key":"2199_CR25","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1161\/CIRCULATIONAHA.109.933911","volume":"122","author":"I Carbone","year":"2010","unstructured":"Carbone I, Francone M, Chimenti C, Galea N, Russo M, Frustaci A (2010) Images in cardiovascular medicine: right ventricular late enhancement as a magnetic resonance marker of glycogen storage disease. Circulation 122(2):189\u2013190. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.109.933911","journal-title":"Circulation"},{"issue":"6","key":"2199_CR26","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1016\/j.clinimag.2008.04.011","volume":"32","author":"F Fiocchi","year":"2008","unstructured":"Fiocchi F, Ricci C, Ligabue G, Reggianini L, Modena MG, Cenacchi G, Torricelli P (2008) Cardiac delayed enhancement distribution in extralysosomial glycogen storage disease. Clin Imaging 32(6):474\u2013476. https:\/\/doi.org\/10.1016\/j.clinimag.2008.04.011","journal-title":"Clin Imaging"},{"issue":"4","key":"2199_CR27","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1007\/s00415-015-7664-0","volume":"262","author":"F Montagnese","year":"2015","unstructured":"Montagnese F, Barca E, Musumeci O, Mondello S, Migliorato A, Ciranni A, Rodolico C, De Filippi P, Danesino C, Toscano A (2015) Clinical and molecular aspects of 30 patients with late-onset Pompe disease (LOPD): unusual features and response to treatment. J Neurol 262(4):968\u2013978. https:\/\/doi.org\/10.1007\/s00415-015-7664-0","journal-title":"J Neurol"},{"issue":"12","key":"2199_CR28","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.2459\/01.JCM.0000296538.82763.f0","volume":"8","author":"C Silva","year":"2007","unstructured":"Silva C, Moon JC, Elkington AG, John AS, Mohiaddin RH, Pennell DJ (2007) Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. J Cardiovasc Med (Hagerstown) 8(12):1076\u20131079. https:\/\/doi.org\/10.2459\/01.JCM.0000296538.82763.f0","journal-title":"J Cardiovasc Med (Hagerstown)"},{"issue":"8","key":"2199_CR29","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.116.003367","volume":"9","author":"H Yogasundaram","year":"2016","unstructured":"Yogasundaram H, Paterson ID, Graham M, Sergi C, Oudit GY (2016) Glycogen storage disease because of a PRKAG2 mutation causing severe biventricular hypertrophy and high-grade atrio-ventricular block. Circ Heart Fail 9(8):e003367. https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.116.003367","journal-title":"Circ Heart Fail"},{"issue":"6","key":"2199_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1002\/mus.25417","volume":"55","author":"A Pichiecchio","year":"2017","unstructured":"Pichiecchio A, Rossi M, Cinnante C, Colafati GS, De Icco R, Parini R, Menni F, Furlan F, Burlina A, Sacchini M, Donati MA, Fecarotta S, Casa RD, Deodato F, Taurisano R, Di Rocco M (2017) Muscle MRI of classic infantile pompe patients: fatty substitution and edema-like changes. Muscle Nerve 55(6):841\u2013848. https:\/\/doi.org\/10.1002\/mus.25417","journal-title":"Muscle Nerve"},{"issue":"17","key":"2199_CR31","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713239","volume":"24","author":"A Burban","year":"2023","unstructured":"Burban A, Pucy\u0142o S, Sikora A, Opolski G, Grabowski M, Ko\u0142odzi\u0144ska A (2023) Hypertrophic cardiomyopathy versus storage diseases with myocardial involvement. Int J Mol Sci 24(17):13239. https:\/\/doi.org\/10.3390\/ijms241713239","journal-title":"Int J Mol Sci"},{"key":"2199_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.1221140","volume":"11","author":"R Colburn","year":"2024","unstructured":"Colburn R, Lapidus D (2024) An analysis of Pompe newborn screening data: a new prevalence at birth, insight and discussion. Front Pediatr 11:1221140. https:\/\/doi.org\/10.3389\/fped.2023.1221140","journal-title":"Front Pediatr"},{"key":"2199_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgmr.2022.100929","volume":"33","author":"V Gragnaniello","year":"2022","unstructured":"Gragnaniello V, Pijnappel PWWM, Burlina AP, In \u2019t Groen SLM, Gueraldi D, Cazzorla C, Maines E, Polo G, Salviati L, Di Salvo G, Burlina AB (2022) Newborn screening for Pompe disease in Italy: long-term results and future challenges. Mol Genet Metab Rep 33:100929. https:\/\/doi.org\/10.1016\/j.ymgmr.2022.100929","journal-title":"Mol Genet Metab Rep"},{"issue":"2","key":"2199_CR34","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1212\/01.wnl.0000251268.41188.04","volume":"68","author":"PS Kishnani","year":"2007","unstructured":"Kishnani PS, Corzo D, Nicolino M, Byrne B, Mandel H, Hwu WL, Leslie N, Levine J, Spencer C, McDonald M, Li J, Dumontier J, Halberthal M, Chien YH, Hopkin R, Vijayaraghavan S, Gruskin D, Bartholomew D, van der Ploeg A, Clancy JP, Parini R, Morin G, Beck M, la De Gastine GS, Jokic M, Thurberg B, Richards S, Bali D, Davison M, Worden MA, Chen YT, Wraith JE (2007) Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology 68(2):99\u2013109. https:\/\/doi.org\/10.1212\/01.wnl.0000251268.41188.04","journal-title":"Neurology"},{"key":"2199_CR35","doi-asserted-by":"publisher","first-page":"S431","DOI":"10.1007\/s10545-008-1000-0","volume":"2","author":"MA Hamdan","year":"2008","unstructured":"Hamdan MA, Almalik MH, Mirghani HM (2008) Early administration of enzyme replacement therapy for Pompe disease: short-term follow-up results. J Inherit Metab Dis 2:S431\u2013S436. https:\/\/doi.org\/10.1007\/s10545-008-1000-0","journal-title":"J Inherit Metab Dis"},{"key":"2199_CR36","doi-asserted-by":"publisher","first-page":"S389","DOI":"10.1007\/s10545-010-9195-2","volume":"3","author":"M Del Rizzo","year":"2010","unstructured":"Del Rizzo M, Fanin M, Cerutti A, Cazzorla C, Milanesi O, Nascimbeni AC, Angelini C, Giordano L, Bordugo A, Burlina AB (2010) Long-term follow-up results in enzyme replacement therapy for Pompe disease: a case report. J Inherit Metab Dis 3:S389\u2013S393. https:\/\/doi.org\/10.1007\/s10545-010-9195-2","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"2199_CR37","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1002\/jmri.27639","volume":"54","author":"A Meloni","year":"2021","unstructured":"Meloni A, Martini N, Positano V, D\u2019Angelo G, Barison A, Todiere G, Grigoratos C, Barra V, Pistoia L, Gargani L, Ripoli A, Pepe A (2021) Myocardial T1 values at 1.5\u2009T: normal values for General Electric scanners and sex-related differences. J Magn Reson Imaging 54(5):1486\u20131500. https:\/\/doi.org\/10.1002\/jmri.27639","journal-title":"J Magn Reson Imaging"},{"issue":"5","key":"2199_CR38","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1007\/s00330-021-08396-6","volume":"32","author":"A Meloni","year":"2022","unstructured":"Meloni A, Nicola M, Positano V, D\u2019Angelo G, Barison A, Todiere G, Grigoratos C, Keilberg P, Pistoia L, Gargani L, Ripoli A, Pepe A (2022) Myocardial T2 values at 1.5 T by a segmental approach with healthy aging and gender. Eur Radiol 32(5):2962\u20132975. https:\/\/doi.org\/10.1007\/s00330-021-08396-6","journal-title":"Eur Radiol"},{"issue":"8","key":"2199_CR39","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1111\/j.1460-9592.2007.02215.x","volume":"17","author":"LY Wang","year":"2007","unstructured":"Wang LY, Ross AK, Li JS, Dearmey SM, Mackey JF, Worden M, Corzo D, Morgan C, Kishnani PS (2007) Cardiac arrhythmias following anesthesia induction in infantile-onset Pompe disease: a case series. Paediatr Anaesth 17(8):738\u2013748. https:\/\/doi.org\/10.1111\/j.1460-9592.2007.02215.x","journal-title":"Paediatr Anaesth"},{"issue":"1","key":"2199_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12968-017-0389-8","volume":"19","author":"DR Messroghli","year":"2017","unstructured":"Messroghli DR, Moon JC, Ferreira VM, Grosse-Wortmann L, He T, Kellman P, Mascherbauer J, Nezafat R, Salerno M, Schelbert EB, Taylor AJ, Thompson R, Ugander M, van Heeswijk RB, Friedrich MG (2017) Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: a consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson 19(1):75. https:\/\/doi.org\/10.1186\/s12968-017-0389-8","journal-title":"J Cardiovasc Magn Reson"},{"issue":"5","key":"2199_CR41","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1111\/bjh.15595","volume":"183","author":"A Pepe","year":"2018","unstructured":"Pepe A, Meloni A, Pistoia L, Cuccia L, Gamberini MR, Lisi R, D\u2019Ascola DG, Rosso R, All\u00f2 M, Spasiano A, Restaino G, Righi R, Mangione M, Positano V, Ricchi P (2018) MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine. Br J Haematol 183(5):783\u2013795. https:\/\/doi.org\/10.1111\/bjh.15595","journal-title":"Br J Haematol"},{"key":"2199_CR42","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ijcard.2023.01.066","volume":"376","author":"A Meloni","year":"2023","unstructured":"Meloni A, Gargani L, Bruni C, Cavallaro C, Gobbo M, D\u2019Agostino A, D\u2019Angelo G, Martini N, Grigioni F, Sinagra G, De Caterina R, Quaia E, Mavrogeni S, Cademartiri F, Matucci-Cerinic M, Pepe A (2023) Additional value of T1 and T2 mapping techniques for early detection of myocardial involvement in scleroderma. Int J Cardiol 376:139\u2013146. https:\/\/doi.org\/10.1016\/j.ijcard.2023.01.066","journal-title":"Int J Cardiol"}],"container-title":["La radiologia medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11547-026-02199-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11547-026-02199-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T17:04:24Z","timestamp":1784048664000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11547-026-02199-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,25]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["2199"],"URL":"https:\/\/doi.org\/10.1007\/s11547-026-02199-9","relation":{},"ISSN":["1826-6983"],"issn-type":[{"value":"1826-6983","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,25]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This is a systematic literature review; no ethical approval is required.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","label":"Ethics standards","group":{"name":"EthicsHeading","label":"Declarations"}}]}}